Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Atrial Natriuretic Peptide During Perioperative Period for Completely Resected NSCLC (JANP study)
jRCTs051180052Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised trial of carperitide in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Relapse-free survival. Started Sep 2015; status: completed.
02
Drugs
carperitide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs051180052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180052.